QIPT vs. DRTS, ARAY, CVRX, OBIO, CLPT, DCTH, PROF, TELA, KRMD, and BWAY
Should you be buying Quipt Home Medical stock or one of its competitors? The main competitors of Quipt Home Medical include Alpha Tau Medical (DRTS), Accuray (ARAY), CVRx (CVRX), Orchestra BioMed (OBIO), ClearPoint Neuro (CLPT), Delcath Systems (DCTH), Profound Medical (PROF), TELA Bio (TELA), KORU Medical Systems (KRMD), and BrainsWay (BWAY). These companies are all part of the "surgical & medical instruments" industry.
Quipt Home Medical (NASDAQ:QIPT) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation, institutional ownership, community ranking and media sentiment.
Quipt Home Medical received 13 more outperform votes than Alpha Tau Medical when rated by MarketBeat users. Likewise, 82.76% of users gave Quipt Home Medical an outperform vote while only 57.89% of users gave Alpha Tau Medical an outperform vote.
42.9% of Quipt Home Medical shares are held by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are held by institutional investors. 4.2% of Quipt Home Medical shares are held by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Alpha Tau Medical has a net margin of 0.00% compared to Quipt Home Medical's net margin of -1.50%. Quipt Home Medical's return on equity of -3.57% beat Alpha Tau Medical's return on equity.
Quipt Home Medical has higher revenue and earnings than Alpha Tau Medical. Quipt Home Medical is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.
Quipt Home Medical has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Comparatively, Alpha Tau Medical has a beta of 0.75, indicating that its stock price is 25% less volatile than the S&P 500.
In the previous week, Alpha Tau Medical had 1 more articles in the media than Quipt Home Medical. MarketBeat recorded 4 mentions for Alpha Tau Medical and 3 mentions for Quipt Home Medical. Alpha Tau Medical's average media sentiment score of 0.95 beat Quipt Home Medical's score of 0.47 indicating that Alpha Tau Medical is being referred to more favorably in the news media.
Quipt Home Medical currently has a consensus price target of $10.00, indicating a potential upside of 147.52%. Alpha Tau Medical has a consensus price target of $12.00, indicating a potential upside of 347.76%. Given Alpha Tau Medical's stronger consensus rating and higher possible upside, analysts plainly believe Alpha Tau Medical is more favorable than Quipt Home Medical.
Summary
Alpha Tau Medical beats Quipt Home Medical on 9 of the 17 factors compared between the two stocks.
Get Quipt Home Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for QIPT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding QIPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Quipt Home Medical Competitors List
Related Companies and Tools
